Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
For peptide manufacturers and GLP-1 CMOs and CDMOs, this creates a new challenge: scaling complex peptide synthesis while maintaining the purity, consistency, and cost efficiency expected for commercial APIs
The questionnaire is the substantive work
The GLP-1s are looked at as high-efficacy products, explained Casberg
Meanwhile, Novo Nordisk and Eli Lilly surged into the ranks of the worlds most valuable companies, pipelines swelling with oral formulations, dual and triple agonists, and weight-loss hybrids that fold in amylin and other pathways
US$ 22.51
US$ 29.00
US$ 24.73
